Search results
Results from the WOW.Com Content Network
Prior to studying medicine, Robert Malone studied computer science at Santa Barbara City College for two years, acting as a teaching assistant in 1981. [2] [8] He received his BS in biochemistry from the University of California, Davis in 1984, his MS in biology from the University of California, San Diego in 1988, and his MD from Northwestern University Feinberg School of Medicine in 1991.
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Timeline of some key discoveries and advances in the development of mRNA-based drug technology. The first successful transfection of designed mRNA packaged within a liposomal nanoparticle into a cell was published in 1989. [18] [19] "Naked" (or unprotected) lab-made mRNA was injected a year later into the muscle of mice.
Two pioneering scientists who created the technology behind life-saving Covid-19 vaccines have won the Nobel Prize in medicine or physiology.
In a 2011 article published by Time, [4] Ayyadurai claimed to have invented email, as a teenager; in August 1982, he registered the copyright on an email application he had written, asserting in his copyright filing, "I, personnally, feel EMAIL is as sophisticated as any electronic mail system on the market today." Historians strongly dispute ...
For premium support please call: 800-290-4726 more ways to reach us
Thomas Midgley Jr. (May 18, 1889 – November 2, 1944) was an American mechanical and chemical engineer.He played a major role in developing leaded gasoline (tetraethyl lead) and some of the first chlorofluorocarbons (CFCs), better known in the United States by the brand name Freon; both products were later banned from common use due to their harmful impact on human health and the environment.
Initially, MacLachlan and Tekmira turned away from the collaboration. Karikó wanted to team up with Ian MacLachlan because he was the leader of a team that helped advance mRNA technology. Karikó was working on establishing the formulated lipid nanoparticle delivery system that encapsulates mRNA in a dense particle through a mixing process ...